USPTO serial 79303348
ONCOMATRYX PIONEERING STROMAL MEDICINE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- SMITH, TARYN E
- Law office
- TMEG LAW OFFICE 104 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with ONCOMATRYX PIONEERING STROMAL MEDICINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for medical research; regulatory proteins for scientific use; reagents for chemical analyses; diagnostic reagents for scientific use; laboratory reagents for scientific use; reagents for use in immunoserology; chemical products for use in industry and science | ACTIVE | — |
| 005 | Diagnostic reagents for use in clinical or medical laboratories; diagnostic test reagents for medical use; diagnostic products and materials; products for medical diagnostics; antibodies; pharmaceutical products; chemical preparations for medical use | ACTIVE | — |
| 010 | Tracing material analyzers for medical use in diagnostics; diagnostic testing apparatus for use in immunoassay procedures [medical]; diagnostic testing instruments for use in immunoassay procedures [medical]; surgical apparatus and instruments for medical use | ACTIVE | — |
| 042 | Chemical research and analysis services; research and development of new products for others; preparation of biological samples for use in testing and analysis in research laboratories; analysis of the behavior of chemical substances; scientific and technological services; biomedical research services; scientific and industrial research services; medical and pharmacological research services | ACTIVE | — |
| 044 | Medical services; DNA or RNA testing for cancer diagnosis and prognosis; medical diagnostic services [testing and analysis]; medical analysis services provided by medical laboratories for diagnostic and therapeutic purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ONCOMATRYX BIOPHARMA S. L.
- Other trademarks owned by ONCOMATRYX BIOPHARMA, S.A.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ONCOMATRYX PIONEERING STROMAL MEDICINE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 16, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Apr 18, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 3, 2023 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 13, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 13, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 24, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 6, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 6, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 13, 2021 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 13, 2021 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 20, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 1, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 1, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 29, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 28, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 10, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 9, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 5, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 4, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |